Manfred E. Schmidt

Erlangen, BY, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 202 publications

First-line ET plus palbociclib versus standard mono-chemotherapy in high-risk HR-positive/HER2-negative metastatic breast cancer and indication for chemotherapy: primary results from the randomized phase IV PADMA study.

First-line ET plus palbociclib versus standard mono-chemotherapy in high-risk HR-positive/HER2-negative metastatic breast cancer and indication for chemotherapy: primary results from the randomized phase IV PADMA study.

Journal: ESMO open

Published: December 10, 2025

Prospective Phase 2 Trial: Long-term results of a salvage brachytherapy combined with interstitial hyperthermia as Re-Irradiation for locally recurrent prostate Carcinoma.

Prospective Phase 2 Trial: Long-term results of a salvage brachytherapy combined with interstitial hyperthermia as Re-Irradiation for locally recurrent prostate Carcinoma.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: October 31, 2025

Multicenter comparison of different total body irradiation techniques - Results from the DGMP Working group large-field irradiation techniques.

Multicenter comparison of different total body irradiation techniques - Results from the DGMP Working group large-field irradiation techniques.

Journal: Zeitschrift fur medizinische Physik

Published: September 05, 2025

Conditional progression-free survival in patients with metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer treated with first-line ribociclib and endocrine therapy: real-world data from the RIBANNA study.

Conditional progression-free survival in patients with metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer treated with first-line ribociclib and endocrine therapy: real-world data from the RIBANNA study.

Journal: ESMO open

Published: February 03, 2025

Redox-driven mineral and organic associations in Jezero Crater, Mars.

Redox-driven mineral and organic associations in Jezero Crater, Mars.

Journal: Nature

Published: November 13, 2024

Individualized mRNA vaccines evoke durable T cell immunity in adjuvant TNBC.

Individualized mRNA vaccines evoke durable T cell immunity in adjuvant TNBC.

Journal: Nature

Published: November 06, 2024

Fe-phosphates in Jezero Crater as evidence for an ancient habitable environment on Mars.

Fe-phosphates in Jezero Crater as evidence for an ancient habitable environment on Mars.

Journal: Nature communications

Published: October 10, 2024

Haematopoietic gene therapy of non-conditioned patients with Fanconi anaemia-A: results from open-label phase 1/2 (FANCOLEN-1) and long-term clinical trials.

Haematopoietic gene therapy of non-conditioned patients with Fanconi anaemia-A: results from open-label phase 1/2 (FANCOLEN-1) and long-term clinical trials.

Journal: Lancet (London, England)

Published: March 12, 2024

hInGeTox: a human-based in vitro platform to evaluate lentivirus/host interactions that contribute to genotoxicity.

hInGeTox: a human-based in vitro platform to evaluate lentivirus/host interactions that contribute to genotoxicity.

Journal: Gene therapy

Published: January 05, 2024

A case of T-cell acute lymphoblastic leukemia in retroviral gene therapy for ADA-SCID.

A case of T-cell acute lymphoblastic leukemia in retroviral gene therapy for ADA-SCID.

Journal: Nature communications

Published: October 13, 2023

Implementation and validation of 2-D-array based tests in routine linac quality assurance.

Implementation and validation of 2-D-array based tests in routine linac quality assurance.

Journal: Zeitschrift fur medizinische Physik

Published: October 04, 2023

Pharmacological and pre-clinical safety profile of rSIV.F/HN, a hybrid lentiviral vector for cystic fibrosis gene therapy.

Pharmacological and pre-clinical safety profile of rSIV.F/HN, a hybrid lentiviral vector for cystic fibrosis gene therapy.

Journal: The European respiratory journal

Published: October 02, 2023

Showing 1-12 of 202

Last Updated: 09/26/2026